Ko Yan Announces Shareholders' Approval to Lift Non-Compete Restrictions for Newly Appointed Directors

1. Shareholders' Meeting Resolution Date: 115/06/29 2. Names and Titles of Directors Permitted to Engage in Competitive Activities: Han Kai-Cheng / Director Yang Ming-Gong / Director Yang Li-Shu-Lan / Director Han Tai-Wei / Director Pan Zong-Wei / Director 3. Approved Competitive Activities: Han Kai-Cheng: Director, UNI PROFIT INDUSTRIAL LIMITED Yang Ming-Gong: (1) Representative of Corporate Director, Chia Bi Qi International Co., Ltd. (2) General Manager, Ding Chun Investment Co., Ltd. Yang Li-Shu-Lan: Responsible Person, Ding Chun Investment Co., Ltd. Han Tai-Wei: Legal Representative, Cheng Ze Medical Devices (Shanghai) Co., Ltd. Pan Zong-Wei: Enterprise Responsible Person, Cheng Ze Medical Devices (Shanghai) Co., Ltd. 4. Duration of Approved Competitive Activities: During tenure as director of the company 5. Resolution Outcome (Voting Results per Article 209 of the Company Act): Approved by shareholders present at the 115th annual general meeting, with affirmative votes exceeding the statutory threshold. 6. Directors Engaging in Competitive Activities Related to Mainland China Businesses (Enter 'Not Applicable' if not applicable): (1) Director Han Tai-Wei (2) Director Pan Zong-Wei 7. Company Name and Position Held in the Mainland China Entity: (1) Legal Representative, Cheng Ze Medical Devices (Shanghai) Co., Ltd. (2) Enterprise Responsible Person, Cheng Ze Medical Devices (Shanghai) Co., Ltd. 8. Address of the Mainland China Entity: (1) Room 208 & 210, Building 4, No.1232 Dingxi Road, Changning District, Shanghai (2) Room 208 & 210, Building 4, No.1232 Dingxi Road, Changning District, Shanghai 9. Business Scope of the Mainland China Entity: (1) Wholesale, import, and export of medical devices and cosmetics (2) Wholesale, import, and export of medical devices and cosmetics 10. Impact on the Company's Financial and Business Operations: None 11. If Directors Have Invested in the Mainland China Entity, Investment Amount and Shareholding Ratio: Not Applicable 12. Other Matters to Be Disclosed: None